MEDINCELL Revenue and Competitors

Jacou,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • MEDINCELL's estimated annual revenue is currently $35.8M per year.(i)
  • MEDINCELL's estimated revenue per employee is $201,000

Employee Data

  • MEDINCELL has 178 Employees.(i)
  • MEDINCELL grew their employee count by -3% last year.

MEDINCELL's People

NameTitleEmail/Phone
1
Head LegalReveal Email/Phone
2
Head Pharmaceutical OperationsReveal Email/Phone
3
Head CommunicationsReveal Email/Phone
4
Chief People OfficerReveal Email/Phone
5
Chief Medical Officer at MedinCell, Inc, Montpelier, FranceReveal Email/Phone
6
Research DirectorReveal Email/Phone
7
Chief Business OfficerReveal Email/Phone
8
Senior Communications OfficerReveal Email/Phone
9
Senior Clinical Project ManagerReveal Email/Phone
10
Project managerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is MEDINCELL?

Better Medicine for All Our team is dedicated to give access to revolutionary medical treatment technologies to all, regardless of local economic conditions. Thanks to our versatile drug delivery technology and research achievements in controlled release of treatments, we aim to bring a paradigm-shift in patient care. MedinCell already targets several therapeutic areas with long-acting medicines that will soon allow a better compliance , an increased patient safety and an optimized treatment efficacy. Our goal is to make medicine better, affordable and sustainable. To achieve it, we rely on strong collaborations, with the academy, NGOs and industrial partners. Our approach to market needs relies on tight interactions with patients and practitioners, so they can express the unmet medical needs they face, and we can work on relevant and efficient solutions. We have built a work environment combining the power of the group and the respect of each individuality. We dedicate ourselves to purposeful innovation and work in total transparency and trust. MedinCell collaborators co-own the company and are deeply committed to pursue our mission: to develop affordable best in class medicines. We change patient management by making it safer, more accurate, optimized. #BetterMedicineForAll #ImpactHealth #GlobalHealth #ControlledRelease #CreativeThinking #InnovationForward #Science

keywords:N/A

N/A

Total Funding

178

Number of Employees

$35.8M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MEDINCELL News

2022-04-17 - MedinCell provides additional information regarding the new ...

Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient,...

2022-04-17 - FDA swats back Teva, MedinCell's long-acting schizophrenia drug application

Hoping to muscle-in on the crowded schizophrenia market, Teva and French biotech MedinCell have been stopped in their tracks by the FDA.

2022-04-17 - Teva, MedinCell Schizophrenia Drug Delayed over FDA Concerns

The FDA has issued a Complete Response Letter (CRL) for TV-46000/mdc-IRM (risperidone extended-release injectable suspension for...